Omrix Biopharmaceuticals, Inc. (OMRI)

TMFBreakerThiel (< 20) Submitted: 10/24/06 4:09 PM : Start Price: $19.60 OMRI Score: -10.48

New hemostat product should be best-in-class in a $700M+ worldwide market. We won't have to wait long--new launches are imminent. (King Pharmaceuticals already has revenue of $220M+ on an inferior product). Plus, this isn't your typical biotech swing...

Report this Post Replies: 0 | Reply | Permalink

PrincetonAl (< 20) Submitted: 8/22/06 5:42 PM : Start Price: $15.22 OMRI Score: 7.78

Profitable commercial stage biotech trading at 10x EPS ... more indications coming on line to continue to allow expansion and growth, no analysts are predicted its latest quarter of profitable, its underfollowed for now ... but expect this to pop a g...

Report this Post Replies: 0 | Reply | Permalink

NetscribeBiotech (76.22) Submitted: 3/12/07 5:16 AM : Start Price: $38.00 OMRI Score: -48.37

Omrix Biopharmaceuticals, Inc. (Omrix) is a biopharmaceutical company that utilizes its protein purification technology and manufacturing know-how to develop biosurgical and passive immunotherapy products derived from human plasma.


The co...

Report this Post Replies: 1 | Reply | Permalink

screach (57.11) Submitted: 3/06/08 1:23 PM : Start Price: $14.92 OMRI Score: 11.00

Market overreacted to earnings disappointment

Report this Post Replies: 0 | Reply | Permalink

KenN513 (93.32) Submitted: 7/16/07 11:31 AM : Start Price: $33.33 OMRI Score: 33.73

PEG is 3+. Other indicators are good, but the market has valued them.

Report this Post Replies: 0 | Reply | Permalink

kcanant (95.96) Submitted: 3/21/08 1:31 AM : Start Price: $12.59 OMRI Score: 31.99

RB biologic hemostasis

Report this Post Replies: 0 | Reply | Permalink

poliyum (80.12) Submitted: 1/10/07 9:19 AM : Start Price: $32.60 OMRI Score: -41.29

I think the key to this company is the research being done for avian influenza and also government contracts to deal with various problems helath problems resulting from bio-terrorism. Teh partnering with JNJ looks promising.
Biotech is full of pitfa...

Report this Post Replies: 0 | Reply | Permalink

tiobueno (28.81) Submitted: 4/04/08 12:25 PM : Start Price: $15.72 OMRI Score: 9.47

March 20, 2008 4:57 PM EDT

Omrix Biopharmaceuticals, Inc. (Nasdaq: OMRI) CEO, Robert Taub, bought 80,000 shares from 03/19-03/20 at prices from $12.10-$12.31, bringing his stake to 2,797,103 shares.

Shares of Omrix Biopharmaceuticals are trading ne...

Report this Post Replies: 0 | Reply | Permalink

TMFBreakerJava (98.36) Submitted: 11/22/06 10:31 AM : Start Price: $31.35 OMRI Score: -39.24

Prospects for growth in surgical sealant field and a partnership with J&J make this profitable biotech a likely outperformer.

Report this Post Replies: 0 | Reply | Permalink

sunnybrasil (88.11) Submitted: 4/05/08 8:33 PM : Start Price: $15.85 OMRI Score: 8.96

The company has reached a reasonable P/E rating and is a speculitive buy.

Report this Post Replies: 0 | Reply | Permalink